Sort by
Refine Your Search
-
Category
-
Program
-
Employer
- King's College London
- UNIVERSITY OF SOUTHAMPTON
- University of Glasgow
- University of Manchester
- Babraham Institute;
- Queen Mary University of London
- The University of Manchester;
- University of Cambridge
- University of Nottingham
- University of Nottingham;
- University of Oxford
- University of Sheffield
- 2 more »
- « less
-
Field
-
their website at https://www.naritalab.com/ Our laboratory investigates the biology of preneoplastic cell states, with particular interest in how changes in cell functional identity and plasticity are controlled
-
, bioelectrical signalling and fibrotic cell-state transition. More information on the project can be found here: https://marcfernandezyague.com The successful candidate will conduct experiments at the Queen Mary
-
al. Nature Genetics 2020, Costea et al. and Schoeberl et al., Mol Cell 2023, Mol Cell 2025). For a list of ongoing projects and publications, please visit: https://www.kcl.ac.uk/research/pavri-group
-
modalities in the rodent brain (3D light-sheet microscopy, spatial transcriptomics and MRI of the same brain) to learn MRI contrasts that can depict neuronal and glial cell density and morphology. You will
-
modalities in the rodent brain (3D light-sheet microscopy, spatial transcriptomics and MRI of the same brain) to learn MRI contrasts that can depict neuronal and glial cell density and morphology. You will
-
. Working closely with stem cell biologists, immunologists, and bioengineers across the MIMIC consortium, the PDRA will: Develop and optimise iPSC‑derived adipocyte differentiation protocols Generate 3D
-
CureHeart (https://cureheart.org/) team at the University of Oxford. CureHeart is an Oxford-led international research programme aiming to develop cures for inherited cardiomyopathies using advanced genetic
-
/ . The successful candidate will receive hands-on training in isolation and culture of different primary human cells from patient lung tissues, and in differentiation of these cells into 2D and 3D tissue-like
-
processing, cell and bacterial culture, and imaging workflows underpinning studies of disease progression and treatment response. This work sits within a wider programme applying tissue-engineered, in vivo
-
to overcome a critical challenge in space bioprinting: the safe storage, transport and deployment of cell‑laden bioinks in extreme environments. You will help develop cryopreservable “cryobioinks” inspired by